Phosphorylated α-synuclein in Parkinson’s disease: correlation depends on disease severity
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Phosphorylated α-synuclein in Parkinson’s disease: correlation depends on disease severity
Authors
Keywords
Parkinson’s disease, Cerebrospinal fluid, Biomarker, α-synuclein, Phosphorylation, DATATOP
Journal
Acta Neuropathologica Communications
Volume 3, Issue 1, Pages -
Publisher
Springer Nature
Online
2015-01-30
DOI
10.1186/s40478-015-0185-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cerebrospinal Fluid α-Synuclein Predicts Cognitive Decline in Parkinson Disease Progression in the DATATOP Cohort
- (2014) Tessandra Stewart et al. AMERICAN JOURNAL OF PATHOLOGY
- Correlation of Parkinson Disease Severity and18F-DTBZ Positron Emission Tomography
- (2014) Ing-Tsung Hsiao et al. JAMA Neurology
- Longitudinal assessment of tau and amyloid beta in cerebrospinal fluid of Parkinson disease
- (2013) Jing Zhang et al. ACTA NEUROPATHOLOGICA
- Biomarkers of mild traumatic brain injury in cerebrospinal fluid and blood
- (2013) Henrik Zetterberg et al. Nature Reviews Neurology
- A longitudinal study on α-synuclein in blood plasma as a biomarker for Parkinson's disease
- (2013) Penelope G. Foulds et al. Scientific Reports
- Changes in properties of serine 129 phosphorylated α-synuclein with progression of Lewy-type histopathology in human brains
- (2012) Douglas G. Walker et al. EXPERIMENTAL NEUROLOGY
- Phosphorylated α-synuclein can be detected in blood plasma and is potentially a useful biomarker for Parkinson's disease
- (2011) Penelope G. Foulds et al. FASEB JOURNAL
- Authentically Phosphorylated -Synuclein at Ser129 Accelerates Neurodegeneration in a Rat Model of Familial Parkinson's Disease
- (2011) H. Sato et al. JOURNAL OF NEUROSCIENCE
- Converging environmental and genetic pathways in the pathogenesis of Parkinson's disease
- (2011) Lena F. Burbulla et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Post mortem cerebrospinal fluid α-synuclein levels are raised in multiple system atrophy and distinguish this from the other α-synucleinopathies, Parkinson's disease and Dementia with Lewy bodies
- (2011) P.G. Foulds et al. NEUROBIOLOGY OF DISEASE
- Cerebrospinal fluid amyloid and tau in LRRK2 mutation carriers
- (2011) J. O. Aasly et al. NEUROLOGY
- Molecular pathways in sporadic PD
- (2011) Enza Maria Valente et al. PARKINSONISM & RELATED DISORDERS
- In vivo demonstration that -synuclein oligomers are toxic
- (2011) B. Winner et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cerebrospinal fluid biomarkers for Parkinson disease diagnosis and progression
- (2010) Min Shi et al. ANNALS OF NEUROLOGY
- DJ-1 and α-synuclein in human cerebrospinal fluid as biomarkers of Parkinson’s disease
- (2010) Zhen Hong et al. BRAIN
- Serine 129 Phosphorylation Reduces the Ability of α-Synuclein to Regulate Tyrosine Hydroxylase and Protein Phosphatase 2Ain Vitroandin Vivo
- (2010) Haiyan Lou et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Pre-fibrillar α-synuclein variants with impaired β-structure increase neurotoxicity in Parkinson's disease models
- (2009) Damla Pinar Karpinar et al. EMBO JOURNAL
- α-Synuclein Aggregation and Ser-129 Phosphorylation-dependent Cell Death in Oligodendroglial Cells
- (2009) Christine L. Kragh et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- α-Synuclein S129 Phosphorylation Mutants Do Not Alter Nigrostriatal Toxicity in a Rat Model of Parkinson Disease
- (2009) Nikolaus R. McFarland et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Phosphorylation at Ser-129 but Not the Phosphomimics S129E/D Inhibits the Fibrillation of α-Synuclein
- (2008) Katerina E. Paleologou et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Specificity and Regulation of Casein Kinase-Mediated Phosphorylation of α-Synuclein
- (2008) Elisa A. Waxman et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- The Sydney multicenter study of Parkinson's disease: The inevitability of dementia at 20 years
- (2008) Mariese A. Hely et al. MOVEMENT DISORDERS
- Clinical and pathological characteristics of patients with Leucine-rich repeat kinase-2 mutations
- (2008) Jason P. Covy et al. MOVEMENT DISORDERS
- The phosphorylation state of Ser-129 in human -synuclein determines neurodegeneration in a rat model of Parkinson disease
- (2008) O. S. Gorbatyuk et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now